Quality-of-Life Improvements in Cutaneous T-Cell Lymphoma Patients Treated with Denileukin Diftitox (ONTAK®) - Concepedia

Concepedia

Publication | Closed Access

Quality-of-Life Improvements in Cutaneous T-Cell Lymphoma Patients Treated with Denileukin Diftitox (ONTAK®)

98

Citations

24

References

2002

Year

Madeleine Duvic, Timothy M. Kuzel, Elise A. Olsen, Ann Martin, Francine M. Foss, Youn H. Kim, Peter Heald, Patricia Bacha, Jean Nichols, Astra M. Liepa

Clinical Lymphoma

Clinical ImmunologyLymphoid NeoplasiaQuality-of-life ImprovementsMedicineImmunodeficienciesImmunologyTumor ImmunityDenileukin DiftitoxImmune Checkpoint InhibitorDermatologyImmunotherapyOncology

References

	Year	Citations

Page 1

Page 1